Utility of CA15-3 as a Tumour Proliferation Marker in Breast Carcinoma Patients: A Cross-sectional Study Protocol

View Full Paper

Ask AI

Bookmark

CA 15-3 levels will be evaluated in patients prior to surgery to help predict tumour behaviour.
The study expects to find higher CA 15-3 levels in malignant breast tumours, aiding in preoperative staging.
Observational study spanning two years will involve 50 female patients diagnosed with breast carcinoma.
Validating CA 15-3 may support enhanced detection and treatment strategies for patients with breast cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Cross-sectional study examines CA 15-3 levels in breast cancer patients, suggesting potential for improved diagnosis and treatment outcomes.

Pande et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Cross-sectional study examines CA 15-3 levels in breast cancer patients, suggesting potential for improved diagnosis and treatment outcomes.